Personalised Medicine in Cancer - Catalunya: A pilot study on the impact of genomic testing in the decision-making process in Oncology (PERIS 2016-2020)
Knowledge of the molecular mechanisms of cancer, the new DNA sequencing technologies and the expansion of new therapies aimed at specific targets are key elements for developing a personalised medicine (PM) based on genomics. The best results obtained with personalized oncological therapies justify...
Coordinator: Elias Campo (IDIBAPS, Spain)
Undiagnosed Rare Diseases of Catalonia (PERIS 2016-2020)
This URDCat Project aims to develop a model of health care directed to patients affected by non-Diagnosed Neurological Rare Diseases, in order to use the knowledge derived from the omic technologies, that allows to integrate clinical sciences with the capability for study and analyze the...
Coordinator: Luis Pérez-Jurado (IMIM, Spain)
SPIDIA for Personalized Medicine - Standardisation of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine
SPIDIA4P is a 48-month project funded by the European Commission under de H2020 program that brings together key experts of 19 stakeholder organisations, with the needed critical mass in knowledge on pre-analytical and analytical procedures, on European and international standardisation...
Coordinator: Uwe Oelmüller
Promoting SINgle cell GEnomics to explore the ecology and evolution of hidden microeuKaryotes
Microbial eukariotes cover the widest phylogenetic diversity in the eukaryotic tree of life and are essential components of all Earth’s ecosystems. Paradoxically, they remain large unknown, hiding a wealth of genes and genomes that are key to understand the ecology and evolution of microbial...
Coordinator: Ramon Massana (ICM-CSIC, Spain)
Breast CAncer STratification - Understanding the determinants of risk and prognosis of molecular breast cancer subtypes. The aim of B-CAST is to identify women at moderate to high risk of breast cancer, the subtype of cancer that is most likely to develo
The B-CAST project (Breast CAncer STratification) is coordinated by the Netherlands Cancer Institute Antoni Van Leeuwenhoek and it will be conducted over five years (until September 2020). Breast tumours are heterogeneous, and result from the complex interplay of multiple lifestyle/environmental...
Coordinator: Marjanka Schmidt
A distributed infrastructure for life-science information - Building a sustainable European infrastructure for biological information, supporting life science research and its translation to medicine, agriculture, bioindustries and society
From September 2015, ‘ELIXIR-EXCELERATE’ is facilitating the integration of Europe’s bioinformatics resources, supporting all sectors of life-science R&D. It will deliver excellence to ELIXIR’s users by fast-tracking the development and deployment of essential data services. EXCELERATE funding...
Coordinator: Niklas Bloomberg

Pages